表紙:バイオインフォマティクスサービスの世界市場 (~2026年):タイプ (シーケンス・データ分析・発見・遺伝子発現・データベース管理)・専門分野 (医療・植物・法医学)・用途 (ゲノミクス・メタボロミクス)・エンドユーザー (学術機関・製薬&バイオテクノロジー)・地域別
市場調査レポート
商品コード
1017515

バイオインフォマティクスサービスの世界市場 (~2026年):タイプ (シーケンス・データ分析・発見・遺伝子発現・データベース管理)・専門分野 (医療・植物・法医学)・用途 (ゲノミクス・メタボロミクス)・エンドユーザー (学術機関・製薬&バイオテクノロジー)・地域別

Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), Enduser (Academia, Pharma-biotech)- Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 231 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
バイオインフォマティクスサービスの世界市場 (~2026年):タイプ (シーケンス・データ分析・発見・遺伝子発現・データベース管理)・専門分野 (医療・植物・法医学)・用途 (ゲノミクス・メタボロミクス)・エンドユーザー (学術機関・製薬&バイオテクノロジー)・地域別
出版日: 2021年07月02日
発行: MarketsandMarkets
ページ情報: 英文 231 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

バイオインフォマティクスサービスの市場規模は予測期間中15.8%のCAGRで推移し、2021年の25億米ドルから、2026年には53億米ドルの規模に成長すると予測されています。

産業界における応用分野の拡大、バイオインフォマティクスサービスに対する官民の資金提供の増加、熟練した専門家の不足によるアウトソーシングの増加などの要因が同市場の成長を推進しています。

用途別では、ゲノミクスの部門が2020年に最大のシェアを示しています。精密医療の開発に向けたファーマコゲノミック研究の利用の増加、ゲノム研究に対する有利な資金調達シナリオ、先進的なバイオインフォマティクスソリューションやサービスの開発に向けたさまざまなライフサイエンス企業とインフォマティクス企業との提携・協力関係などの要因がシェアの拡大に貢献しています。

当レポートでは、世界のバイオインフォマティクスサービスの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、タイプ・専門分野・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
    • 動向
  • 規制分析
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響

第6章 市場分析・予測:タイプ別

  • シーケンシングサービス
    • 全ゲノムシーケンシング・denovoアセンブリー
    • エクソーム分析
    • トランスクリプトーム分析
    • メタゲノミクス分析
    • チップ配列分析
    • その他の
  • データ分析サービス
    • データマイニング
    • ゲノミクス分析
    • プロテオミクス分析
    • 注釈・発見
  • 創薬サービス
  • 差次的遺伝子発現分析サービス
  • データベース・管理サービス
  • その他

第7章 市場分析・予測:専門分野別

  • 医療バイオテクノロジー
  • 動物バイオテクノロジー
  • 植物バイオテクノロジー
  • 環境バイオテクノロジー
  • 法医学バイオテクノロジー

第8章 市場分析・予測:用途別

  • ゲノミクス
  • ケモインフォマティクス・ドラッグデザイン
  • プロテオミクス
  • トランスクリプトミクス
  • メタボロミクス
  • その他

第9章 市場分析・予測:エンドユーザー別

  • 学術機関・研究センター
  • 病院・クリニック
  • 製薬・バイオテクノロジー企業
  • CRO
  • その他

第10章 市場分析・予測:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要企業の成功戦略
  • 収益分析
  • 市場シェア分析
  • 企業評価クアドラント
  • 競合ベンチマーキング
  • 競合シナリオ・動向

第12章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC
    • EUROFINS SCIENTIFIC
    • ILLUMINA
    • PERKINELMER
    • NEOGENOMICS
    • BASECLEAR
    • CD GENOMICS
    • FIOS GENOMICS
    • GENEWIZ(A BROOKS LIFE SCIENCES COMPANY)
    • PSOMAGEN, INC.(FORMERLY KNOWN AS MACROGEN)
    • MEDGENOME LABS
    • MICROSYNTH
    • QIAGEN N.V.
    • SOURCE BIOSCIENCE
  • 他の有力企業
    • NXT-DX(A DIAGENODE COMPANY)
    • NUCLEOME BIOINFORMATICS
    • 1010GENOME
    • DNANEXUS, INC.
    • BIONIVID

第13章 付録

目次
Product Code: HIT 6200

The bioinformatics services market is projected to reach USD 5.3 Billion by 2026 from USD 2.5 Billion in 2021, at a CAGR of 15.8% during the forecast period. Growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the bioinformatics services market during the forecast period. However, the in-house development of bioinformatics solutions and publicly available bioinformatics tools are expected to limit market are expected to restrain market growth in the coming years.

In terms Application, the genomics segment is expected to account for the largest share of the bioinformatics services market in 2020."

Based on application, the bioinformatics services market is segmented into genomics, chemoinformatics and drug design, proteomics, transcriptomics, metabolomics and other applications. Large share is attributed to genomics segment due to increasing use of pharmacogenomic research for the development of precision medicine, favorable funding scenario for genomic research, and partnerships and collaborations between various life sciences and informatics companies for the development of advanced bioinformatics solutions and services.

"In terms of type segment, sequencing services segment is expected to account for the largest share during the forecast period."

Based on type, the bioinformatics services market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database and management services, and other bioinformatics services. Due to reduced cost of sequencing the sequencing services segment enjoy the major share of the market.

"In terms of specialty segment, medical biotechnology segment is expected to account for the largest share during the forecast period."

Based on specialty, the bioinformatics services market is segmented into medical biotechnology, plant biotechnology, animal biotechnology, environment biotechnology and forensic biotechnology. Medical biotechnology holds the largest share due to the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and increasing funding for the development of bioinformatics solutions for clinical diagnostics.

"The academic institutes and research centers segment is expected to register the highest CAGR during the forecast period" `

Based on end-users, the bioinformatics services market has been segmented as -academic institiutes and research centers, hospitals and clinics, pharma and biotech companies, CROs and other end users. The large share of academic institutes and research centers segment can be attributed to the growing number of bioinformatics-based research studies, increasing scale of genomics research, rising number of collaborations between academic research institutes and players in the bioinformatics market, and the growing number of government funding programs for genomics research.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period."

The bioinformatics services market covers five key geographies-North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region offered significant opportunities for the growth of the bioinformatics services market. The market growth in Asia Pacific can be attributed to the increasing incidence of genetic diseases, rising number of bioinformatics-based research studies, and growing demand for bioinformatics services from various end users.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

Prominent players in the bioinformatics services market include Illumina (US), Thermo Fisher Scientific (US), Eurofins Scientific (Luxembourg), BGI Group (China), NeoGenomics (US), PerkinElmer (US), CD Genomics (US), Psomagen, Inc. (South Korea), QIAGEN (Germany), GENEWIZ (US), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), and BaseClear (Netherlands), among others.

Research Coverage

This report studies the bioinformatics services market based on type, specialty, application, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to five major regions and their respective major countries.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the services offered by the top players in the bioinformatics services market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the bioinformatics services market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the bioinformatics services market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKET SCOPE
    • 1.2.2 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.3 MARKETS COVERED
    • FIGURE 1 BIOINFORMATICS SERVICES MARKET SEGMENTATION
    • 1.2.4 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 BIOINFORMATICS SERVICES MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.2.1 SECONDARY DATA
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET ESTIMATION METHODOLOGY
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 6 MARKET SIZE ESTIMATION: BIOINFORMATICS SERVICES MARKET (BOTTOM-UP APPROACH)
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.4 COVID-19 HEALTH ASSESSMENT
  • 2.5 COVID-19 ECONOMIC ASSESSMENT
  • 2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE BIOINFORMATICS SERVICES MARKET
  • 2.8 DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION
  • 2.9 RESEARCH ASSUMPTIONS
  • 2.10 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 12 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 BIOINFORMATICS SERVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 BIOINFORMATICS SERVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 BIOINFORMATICS SERVICES MARKET OVERVIEW
    • FIGURE 17 GROWING APPLICATIONS OF BIOINFORMATICS TO DRIVE THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
  • 4.2 BIOINFORMATICS SERVICES MARKET, BY TYPE
    • FIGURE 18 SEQUENCING SERVICES SEGMENT WILL CONTINUE TO DOMINATE THE BIOINFORMATICS SERVICES MARKET BY 2026
  • 4.3 ASIA PACIFIC BIOINFORMATICS SERVICES MARKET, BY COUNTRY AND APPLICATION
    • FIGURE 19 GENOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOINFORMATICS SERVICES MARKET
  • 4.4 BIOINFORMATICS SERVICES MARKET, BY END USER
    • FIGURE 20 ACADEMIC INSTITUTES AND RESEARCH CENTERS ARE THE LARGEST END USERS OF BIOINFORMATICS SERVICES
  • 4.5 BIOINFORMATICS SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing applications of bioinformatics in various industries
      • 5.2.1.2 Increasing public-private sector funding for bioinformatics services
    • TABLE 2 PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS
      • 5.2.1.3 Shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects
      • 5.2.1.4 Increasing pharmaceutical and biotech R&D expenditure
    • TABLE 3 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN THE ASIA PACIFIC REGION
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 In-house development of bioinformatics solutions and publicly available bioinformatics tools
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Reducing cost of sequencing and growing volume of data generated during sequencing
    • FIGURE 23 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2019
    • FIGURE 24 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING, 2001-2019
      • 5.2.3.2 Growing focus on outsourcing for the management of large volumes of data
      • 5.2.3.3 Growth potential in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complexity of data
      • 5.2.4.2 Lack of well-defined standards and interoperability issues for bioinformatics analysis
      • 5.2.4.3 Ethical issues
    • 5.2.5 INDUSTRY TRENDS
      • 5.2.5.1 Partnerships & collaborations for technological advancements in the bioinformatics services market
    • FIGURE 25 ECOSYSTEM COVERAGE: PARENT MARKET
  • 5.3 REGULATORY ANALYSIS
    • 5.3.1 GLOBAL ALLIANCE FOR GENOMICS AND HEALTH (GA4GH)
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 26 VALUE CHAIN: BIOINFORMATICS SERVICES WORKFLOW- ANALYSIS PLAYS A CRUCIAL ROLE AFTER CORE SERVICES
  • 5.5 SUPPLY CHAIN ANALYSIS
    • TABLE 4 SUPPLY CHAIN ECOSYSTEM
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 BIOINFORMATICS SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
  • 5.7 COVID-19 IMPACT

6 BIOINFORMATICS SERVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 6 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.2 SEQUENCING SERVICES
    • TABLE 7 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 8 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 9 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 10 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 11 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.1 WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY
      • 6.2.1.1 Launch of advanced whole-genome sequencing services to drive market growth
    • TABLE 12 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.2 EXOME ANALYSIS
      • 6.2.2.1 Rising awareness of exome analysis services to drive market growth
    • TABLE 13 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR EXOME ANALYSIS, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.3 TRANSCRIPTOME ANALYSIS
      • 6.2.3.1 Application of transcriptomics in diagnostics and cancer research is increasing
    • TABLE 14 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR TRANSCRIPTOME ANALYSIS, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.4 METAGENOMIC ANALYSIS
      • 6.2.4.1 Application of metagenomics in human microbiome analysis to drive market growth
    • TABLE 15 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR METAGENOMIC ANALYSIS, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.5 CHIP-SEQ ANALYSIS
      • 6.2.5.1 Increasing awareness about the advantages of ChIP-seq among professionals to drive market growth
    • TABLE 16 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR CHIP-SEQ ANALYSIS, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.6 OTHER SEQUENCING SERVICES
    • TABLE 17 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR OTHER SEQUENCING SERVICES, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 DATA ANALYSIS SERVICES
    • TABLE 18 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 19 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 20 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 21 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 22 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.1 DATA MINING
      • 6.3.1.1 Development of advanced bioinformatics applications and algorithms based on data mining to drive market growth
    • TABLE 23 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR DATA MINING, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 GENOMIC ANALYSIS
      • 6.3.2.1 Growth in the amount of sequencing data and technological advancements in genomic analysis to drive market growth
    • TABLE 24 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR GENOMIC ANALYSIS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.3 PROTEOMIC ANALYSIS
      • 6.3.3.1 Increasing focus on personalized medicine and outsourcing of proteomic studies to drive market growth
    • TABLE 25 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.4 VARIANT ANNOTATION AND DISCOVERY
      • 6.3.4.1 Increasing research on mutation analysis to drive market growth
    • TABLE 26 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR VARIANT ANNOTATION AND DISCOVERY, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 DRUG DISCOVERY SERVICES
    • 6.4.1 ADVANCEMENTS IN PHARMACOGENOMICS TO DRIVE MARKET GROWTH
    • TABLE 27 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 28 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 29 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 30 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.5 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES
    • 6.5.1 R&D FOR THE ADVANCEMENT OF SOLUTIONS & SERVICES FOR DIFFERENTIAL GENE EXPRESSION STUDIES IS INCREASING
    • TABLE 31 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 32 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 33 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 34 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.6 DATABASE AND MANAGEMENT SERVICES
    • 6.6.1 GOVERNMENT INITIATIVES FOR DATA SHARING WILL DRIVE MARKET GROWTH
    • TABLE 35 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 36 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 37 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 38 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.7 OTHER BIOINFORMATICS SERVICES
    • TABLE 39 OTHER BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 40 OTHER BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 41 OTHER BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 42 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)

7 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY

  • 7.1 INTRODUCTION
    • TABLE 43 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
  • 7.2 MEDICAL BIOTECHNOLOGY
    • 7.2.1 USE OF BIOINFORMATICS SERVICES IS INCREASING IN MOLECULAR MEDICINE, DRUG DISCOVERY, AND CLINICAL DIAGNOSTICS
    • TABLE 44 BIOINFORMATICS SERVICES MARKET FOR MEDICAL BIOTECHNOLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 ANIMAL BIOTECHNOLOGY
    • 7.3.1 VAST OMICS DATABASES FOR SEQUENCING & ANALYSIS OF ANIMAL GENOMIC DATA ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 45 BIOINFORMATICS SERVICES MARKET FOR ANIMAL BIOTECHNOLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 PLANT BIOTECHNOLOGY
    • 7.4.1 DECREASING SEQUENCING COST AND ADVANCED BIOINFORMATICS SERVICES TO BOOST MARKET GROWTH
    • TABLE 46 BIOINFORMATICS SERVICES MARKET FOR PLANT BIOTECHNOLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 ENVIRONMENTAL BIOTECHNOLOGY
    • 7.5.1 R&D OF BIOINFORMATICS IN ENVIRONMENTAL BIOTECHNOLOGY TO DRIVE MARKET GROWTH
    • TABLE 47 BIOINFORMATICS SERVICES MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 FORENSIC BIOTECHNOLOGY
    • 7.6.1 IMPROVED USE OF FORENSIC BIOINFORMATICS WILL DRIVE MARKET GROWTH
    • TABLE 48 BIOINFORMATICS SERVICES MARKET FOR FORENSIC BIOTECHNOLOGY, BY REGION, 2019-2026 (USD MILLION)

8 BIOINFORMATICS SERVICES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 49 BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 GENOMICS
    • 8.2.1 GENOMICS IS THE LARGEST APPLICATION SEGMENT IN THE BIOINFORMATICS SERVICES MARKET
    • TABLE 50 BIOINFORMATICS SERVICES MARKET FOR GENOMICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 CHEMOINFORMATICS & DRUG DESIGN
    • 8.3.1 PROACTIVE USE OF CHEMOINFORMATICS IN DRUG DISCOVERY BY PHARMACEUTICAL COMPANIES WILL DRIVE MARKET GROWTH
    • TABLE 51 BIOINFORMATICS SERVICES MARKET FOR CHEMOINFORMATICS & DRUG DESIGN, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 PROTEOMICS
    • 8.4.1 R&D AND FINANCIAL SUPPORT FROM GOVERNMENT AND PRIVATE FUNDING BODIES IS INCREASING IN THE FIELD OF PROTEOMICS
    • TABLE 52 BIOINFORMATICS SERVICES MARKET FOR PROTEOMICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 TRANSCRIPTOMICS
    • 8.5.1 INCREASING NUMBER OF RESEARCH STUDIES FOR THE TREATMENT OF CANCER USING TRANSCRIPTOMICS WILL SUPPORT MARKET GROWTH
    • TABLE 53 BIOINFORMATICS SERVICES MARKET FOR TRANSCRIPTOMICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.6 METABOLOMICS
    • 8.6.1 TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF METABOLOMICS AND DATA ANALYSIS TO DRIVE MARKET GROWTH
    • TABLE 54 BIOINFORMATICS SERVICES MARKET FOR METABOLOMICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.7 OTHER APPLICATIONS
    • TABLE 55 BIOINFORMATICS SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

9 BIOINFORMATICS SERVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 56 BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS
    • 9.2.1 ACADEMIC INSTITUTES AND RESEARCH CENTERS ARE THE LARGEST END USERS OF BIOINFORMATICS SERVICES
    • TABLE 57 BIOINFORMATICS SERVICES MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 HOSPITALS AND CLINICS
    • 9.3.1 GROWING NUMBER OF COLLABORATIONS AND AGREEMENTS BETWEEN COMPANIES AND HOSPITALS TO BOOST MARKET GROWTH
    • TABLE 58 BIOINFORMATICS SERVICES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.4.1 INCREASING FOCUS ON DEVELOPING TARGETED THERAPIES WILL DRIVE THE MARKET GROWTH
    • TABLE 59 BIOINFORMATICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
  • 9.5 CONTRACT RESEARCH ORGANIZATIONS
    • 9.5.1 INCREASING NUMBER OF CROS WILL ENHANCE THE MARKET GROWTH
    • TABLE 60 BIOINFORMATICS SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.6 OTHER END USERS
    • TABLE 61 BIOINFORMATICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

10 BIOINFORMATICS SERVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 62 BIOINFORMATICS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET SNAPSHOT
    • TABLE 63 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 64 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 65 N0RTH AMERICA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 66 NORTH AMERICA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 68 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 69 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Growing R&D activities in the US to drive market growth
    • TABLE 70 US: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 US: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 US: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of bioinformatics services
    • TABLE 73 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 CANADA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 CANADA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 76 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 77 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 78 EUROPE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 EUROPE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 EUROPE: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 81 EUROPE: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 82 EUROPE: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Funding initiatives by the government will drive market growth
    • TABLE 83 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 GERMANY: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 GERMANY: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 UK dominates the bioinformatics services market in Europe
    • TABLE 86 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 UK: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 UK: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Government initiatives to support genomics research-a major factor driving market growth in France
    • TABLE 89 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 FRANCE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 FRANCE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Favorable funding scenario to drive the bioinformatics services market in Italy
    • TABLE 92 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 ITALY: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 ITALY: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing number of conferences focusing on new sequencing technologies and data analysis to support market growth
    • TABLE 95 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 SPAIN: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 SPAIN: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 98 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 ROE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 ROE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET SNAPSHOT
    • TABLE 101 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 102 APAC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 103 APAC: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 APAC: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 APAC: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 106 APAC: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 107 APAC: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Increasing focus on personalized diagnostics products to drive market growth in Japan
    • TABLE 108 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 JAPAN: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 JAPAN: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China is the largest market for bioinformatics services in APAC
    • TABLE 111 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 CHINA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 113 CHINA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing prevalence of target diseases in India to support market growth
    • TABLE 114 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 115 INDIA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 INDIA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth
    • TABLE 117 AUSTRALIA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 AUSTRALIA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 AUSTRALIA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Supportive government initiatives expected to positively impact market growth
    • TABLE 120 SOUTH KOREA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 121 SOUTH KOREA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 SOUTH KOREA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 123 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 ROAPAC: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 ROAPAC: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 126 LATAM: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 127 LATAM: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 LATAM: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 LATAM: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 LATAM: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 131 LATAM: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 132 LATAM: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Focus on NGS technologies and NGS data analysis is increasing in Brazil
    • TABLE 133 BRAZIL: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 BRAZIL: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 BRAZIL: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Economic growth in Mexico to support the growth of the market
    • TABLE 136 MEXICO: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 MEXICO: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 MEXICO: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 139 ROLA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 ROLA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 ROLA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 INCREASING FOCUS ON GENOMICS RESEARCH TO DRIVE MARKET GROWTH IN MEA
    • TABLE 142 MEA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 MEA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 MEA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 MEA: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019-2026 (USD MILLION)
    • TABLE 146 MEA: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 147 MEA: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOINFORMATICS SERVICE PROVIDERS
  • 11.4 REVENUE ANALYSIS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE BIOINFORMATICS SERVICES MARKET
  • 11.5 MARKET SHARE ANALYSIS
    • FIGURE 30 THERMO FISHER SCIENTIFIC HELD THE LEADING POSITION IN THE BIOINFORMATICS SERVICES MARKET IN 2020
  • 11.6 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
  • 11.7 VENDOR INCLUSION CRITERIA
    • 11.7.1 STARS
    • 11.7.2 PERVASIVE PLAYERS
    • 11.7.3 EMERGING LEADERS
    • 11.7.4 PARTICIPANTS
    • FIGURE 31 BIOINFORMATICS SERVICES MARKET: GLOBAL COMPANY EVALUATION MATRIX, 2020
  • 11.8 COMPANY EVALUATION QUADRANT (SMES/STRAT-UPS)
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 STARTING BLOCKS
    • 11.8.3 RESPONSIVE COMPANIES
    • 11.8.4 DYNAMIC COMPANIES
    • FIGURE 32 BIOINFORMATICS SERVICES MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2020 (SME/START-UPS)
  • 11.9 COMPETITIVE BENCHMARKING
    • FIGURE 33 SERVICE AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BIOINFORMATICS SERVICES MARKET
    • TABLE 148 SERVICE FOOTPRINT OF COMPANIES
    • TABLE 149 REGIONAL FOOTPRINT OF COMPANIES
  • 11.10 COMPETITIVE SCENARIO AND TRENDS
    • TABLE 150 BIOINFORMATICS SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2017-MAY 2021
    • TABLE 151 BIOINFORMATICS SERVICES MARKET: EXPANSIONS, JANUARY 2017-MAY 2021
    • TABLE 152 BIOINFORMATICS SERVICES MARKET: DEALS, JANUARY 2017-MAY 2021

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 THERMO FISHER SCIENTIFIC
    • TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
    • TABLE 154 THERMO FISHER SCIENTIFIC: SERVICE OFFERINGS
    • TABLE 155 THERMO FISHER SCIENTIFIC: DEALS
    • TABLE 156 THERMO FISHER SCIENTIFIC: OTHER DEVELOPMENTS
    • 12.1.2 EUROFINS SCIENTIFIC
    • TABLE 157 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 35 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
    • TABLE 158 EUROFINS SCIENTIFIC: SERVICE OFFERINGS
    • TABLE 159 EUROFINS SCIENTIFIC: SERVICE LAUNCHES
    • TABLE 160 EUROFINS SCIENTIFIC: DEALS
    • 12.1.3 ILLUMINA
    • TABLE 161 ILLUMINA: BUSINESS OVERVIEW
    • FIGURE 36 ILLUMINA: COMPANY SNAPSHOT
    • TABLE 162 ILLUMINA: SERVICE OFFERINGS
    • TABLE 163 ILLUMINA: DEALS
    • TABLE 164 ILLUMINA: OTHER DEVELOPMENTS
    • 12.1.4 PERKINELMER
    • TABLE 165 PERKINELMER: BUSINESS OVERVIEW
    • FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT
    • TABLE 166 PERKINELMER: SERVICE OFFERINGS
    • TABLE 167 PERKINELMER: SERVICE LAUNCHES
    • TABLE 168 PERKINELMER: DEALS
    • 12.1.5 NEOGENOMICS
    • TABLE 169 NEOGENOMICS: BUSINESS OVERVIEW
    • FIGURE 38 NEOGENOMICS: COMPANY SNAPSHOT
    • TABLE 170 NEOGENOMICS: SERVICE OFFERINGS
    • TABLE 171 NEOGENOMICS: OTHER DEVELOPMENTS
    • 12.1.6 BASECLEAR
    • TABLE 172 BASECLEAR: BUSINESS OVERVIEW
    • TABLE 173 BASECLEAR: SERVICE OFFERINGS
    • TABLE 174 BASECLEAR: SERVICE LAUNCHES
    • TABLE 175 BASECLEAR: DEALS
    • TABLE 176 BGI GROUP: BUSINESS OVERVIEW
    • TABLE 177 BGI GROUP: SERVICE OFFERINGS
    • TABLE 178 BGI GROUP: DEALS
    • 12.1.8 CD GENOMICS
    • TABLE 179 CD GENOMICS: BUSINESS OVERVIEW
    • TABLE 180 CD GENOMICS: SERVICE OFFERINGS
    • 12.1.9 FIOS GENOMICS
    • TABLE 181 FIOS GENOMICS: BUSINESS OVERVIEW
    • TABLE 182 FIOS GENOMICS: SERVICE OFFERINGS
    • TABLE 183 FIOS GENOMICS: DEALS
    • 12.1.10 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY)
    • TABLE 184 GENEWIZ: BUSINESS OVERVIEW
    • FIGURE 39 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT
    • TABLE 185 GENEWIZ: SERVICE OFFERINGS
    • TABLE 186 GENEWIZ: SERVICE LAUNCHES
    • TABLE 187 GENEWIZ: DEALS
    • TABLE 188 GENEWIZ: OTHER DEVELOPMENTS
    • 12.1.11 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN)
    • TABLE 189 PSOMAGEN, INC.: BUSINESS OVERVIEW
    • TABLE 190 PSOMAGEN: SERVICE OFFERINGS
    • TABLE 191 PSOMAGEN: DEALS
    • TABLE 192 PSOMAGEN: OTHER DEVELOPMENTS
    • 12.1.12 MEDGENOME LABS
    • TABLE 193 MEDGENOME: BUSINESS OVERVIEW
    • TABLE 194 MEDGENOME: SERVICE OFFERINGS
    • 12.1.13 MICROSYNTH
    • TABLE 195 MICROSYNTH: BUSINESS OVERVIEW
    • TABLE 196 MICROSYNTH: SERVICE OFFERINGS
    • TABLE 197 MICROSYNTH: SERVICE LAUNCHES
    • 12.1.14 QIAGEN N.V.
    • TABLE 198 QIAGEN N.V.: BUSINESS OVERVIEW
    • FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT
    • TABLE 199 QIAGEN N.V.: SERVICE OFFERINGS
    • TABLE 200 QIAGEN N.V.: DEALS
    • TABLE 201 QIAGEN N.V.: OTHER DEVELOPMENTS
    • 12.1.15 SOURCE BIOSCIENCE
    • TABLE 202 SOURCE BIOSCIENCE: BUSINESS OVERVIEW
    • FIGURE 41 SOURCE BIOSCIENCE: COMPANY SNAPSHOT
    • TABLE 203 SOURCE BIOSCIENCE: SERVICE OFFERINGS
  • 12.2 OTHER COMPANIES
    • 12.2.1 NXT-DX (A DIAGENODE COMPANY)
    • 12.2.2 NUCLEOME BIOINFORMATICS
    • 12.2.3 1010GENOME
    • 12.2.4 DNANEXUS, INC.
    • 12.2.5 BIONIVID
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS